Nomura Holdings’s Cabaletta Bio CABA Stock Holding History

Nomura Holdings’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-95,512	Closed	-$257K	–	1821
2026 Q1	$257K	Buy	+95,512	New	+$265K	﹤0.01%	1518
2024 Q3	–	Sell	-23,057	Closed	-$172K	–	1578
2024 Q2	$172K	Buy	+23,057	New	+$283K	﹤0.01%	1642

Other funds holding CABA

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Nomura Holdings's CABA Position: Q2 2026 in Review

Nomura Holdings sold out of Cabaletta Bio (CABA) in Q2 2026, closing a stake of 95,512 shares — an estimated $257K sold.

Nomura Holdings first reported a position in CABA in Q2 2024 and held it in 2 quarters. The position peaked at $257K in Q1 2026. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

Nomura Holdings reported no remaining Cabaletta Bio position as of Q2 2026 after selling out during the quarter.
Nomura Holdings sold 95,512 Cabaletta Bio shares in Q2 2026, an estimated $257K.
Nomura Holdings first reported a position in Cabaletta Bio in Q2 2024 and held it in 2 quarters.
Nomura Holdings's Cabaletta Bio position peaked at $257K in Q1 2026.
140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.